Treatment options for EGFR mutation-positive NSCLC patients with leptomeningeal metastases after third-generation TKI resistance: a retrospective real-world study
Background: Leptomeningeal metastasis (LM) is a serious complication of advanced non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutation. There are no guidelines or consensus on the optimal treatment regimens and strategies for LM yet. Objectives: To analyze the infl...
Sparad:
| Huvudupphov: | , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
SAGE Publishing
2025-12-01
|
| Serie: | Therapeutic Advances in Medical Oncology |
| Länkar: | https://doi.org/10.1177/17588359251403396 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|